National Psoriasis Foundation

Drug Pipeline

« Back to the pipeline

Company

Moleculin, Inc

Therapeutic Approach

Topical Treatments

Indication

Psoriasis

Mechanism

anti-inflammatory (p-STAT3 inhibitor)

Phase

Phase II

Get the latest research news and tips on managing your psoriasis and psoriatic arthritis.